Filing Details

Accession Number:
0001179110-12-003109
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-21 16:56:59
Reporting Period:
2012-02-16
Filing Date:
2012-02-21
Accepted Time:
2012-02-21 16:56:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425732 Thomas Underwood 3200 Windy Hill Road
Suite B-100
Atlanta GA 30339
Ceo, Alere Health Llc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-16 750 $18.91 2,250 No 4 M Direct
Common Stock Disposition 2012-02-16 750 $26.02 1,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-02-16 750 $0.00 750 $18.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-31 No 4 M Direct
Footnotes
  1. These options became exercisable in four equal annual installments beginning December 31, 2009.
  2. This derivative security does not have a price.